EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPY
Objective: The aim of this study was to examine the impact of smoking on axial spondyloarthritis (axSpA) patients taking tumor necrosis factor inhibitors (TNFi). Material and Method: Our study consisted of 211 patients who were diagnosed with axSpA and received TNFi treatment in the rheumatology out...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Istanbul University Press
2022-07-01
|
| Series: | İstanbul Tıp Fakültesi Dergisi |
| Subjects: | |
| Online Access: | https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/FA05CA59BD824C8997FB734B51D2D46A |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850190381831946240 |
|---|---|
| author | Özlem Pehlivan Yasemin Yalçınkaya Bahar Artım Esen Nihat Hüseyinsinoğlu Ahmet Gül Murat İnanç Mahdume Lale Öçal |
| author_facet | Özlem Pehlivan Yasemin Yalçınkaya Bahar Artım Esen Nihat Hüseyinsinoğlu Ahmet Gül Murat İnanç Mahdume Lale Öçal |
| author_sort | Özlem Pehlivan |
| collection | DOAJ |
| description | Objective: The aim of this study was to examine the impact of smoking on axial spondyloarthritis (axSpA) patients taking tumor necrosis factor inhibitors (TNFi). Material and Method: Our study consisted of 211 patients who were diagnosed with axSpA and received TNFi treatment in the rheumatology outpatient clinic. The patients were evaluated retrospectively, cross-sectionally and grouped by intensity of smoking (pack-years). Those who smoked>20 pack-years were defined as heavy smokers. Groups were compared in terms of physical examination, laboratory values and disease evaluation indexes (Bath Ankylosing Spondylitis Metrology Index (BASMI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Ankylosing Spondylitis Quality of Life (ASQoL) and Beck Depression Inventory (BDI) scores. Mann-Whitney U and Spearman correlation analysis tests were used for data analysis Results: Comparison of the smoker (n=121) and non-smoker groups (n=90) revealed BASMI was lower in the non-smoker group (p=0.04). Smoking intensity correlated with BDI (r=0.323, p<0.001), BASDAI (r=0.257, p=0.005), BASMI components (lomber lateral flexion (LLF) (r=-0.303, p=0.001), cervical rotation (CR) (r=-0.232, p=0.012), and tragus wall distance (TWD) (r=0.27, p=0.003)). Multivariate analysis revealed an association between the pack-years of smoking and the BASMI [regression coefficient (B)=0.067, standard error (SE)=0.22, 95%CI=0.02, 0.10; p=0.003],baseline (B=pretreatment)-last value (L.=posttreatment) difference of BASFI [B=-0.063, SE=0.02, 95%CI=-0.10, -0.20; p=0.003], of BASDAI [B=-0.047, SE=0.02, 95%CI=-0.08, -0.007; p=0.026], ASQoL [B=-0.125, SE=0.04, 95%CI=0.04, -0.20; p=0.003]. In heavy smokers, significant worsening was found in LLFL (p=0.01), CRL (p=0.04), TWDL (p=0.001), BASFIL (p=0.035) and BASMIL (p=0.001). Significant differences were found in the baseline (B) and last (L) BASDAI (p=0.042), BASFIL (p=0.002), BASFIB-L (p=0.07) and BASMI (p=0.03) values in the nonradiograpic-axSpA group in heavy smokers, compared to the AS group. Conclusion: Our study showed that smoking, especially heavy smoking, has a negative effect in every phase of axSpA. Smoking intensity may correlate with reduced response to TNFi. |
| format | Article |
| id | doaj-art-10da095cf6a94011ae0e01d034ff027b |
| institution | OA Journals |
| issn | 1305-6441 |
| language | English |
| publishDate | 2022-07-01 |
| publisher | Istanbul University Press |
| record_format | Article |
| series | İstanbul Tıp Fakültesi Dergisi |
| spelling | doaj-art-10da095cf6a94011ae0e01d034ff027b2025-08-20T02:15:19ZengIstanbul University Pressİstanbul Tıp Fakültesi Dergisi1305-64412022-07-0185336236910.26650/IUITFD.1053741123456EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPYÖzlem Pehlivan0https://orcid.org/0000-0002-6887-1801Yasemin Yalçınkaya1https://orcid.org/0000-0001-9357-0456Bahar Artım Esen2https://orcid.org/0000-0002-5659-3955Nihat Hüseyinsinoğlu3https://orcid.org/0000-0001-9608-5974Ahmet Gül4https://orcid.org/0000-0001-8219-3720Murat İnanç5https://orcid.org/0000-0002-6376-5583Mahdume Lale Öçal6https://orcid.org/0000-0003-3615-256XSağlık Bilimleri Üniversitesi, Istanbul, Turkiyeİstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Üniversitesi, İstanbul, TürkiyeObjective: The aim of this study was to examine the impact of smoking on axial spondyloarthritis (axSpA) patients taking tumor necrosis factor inhibitors (TNFi). Material and Method: Our study consisted of 211 patients who were diagnosed with axSpA and received TNFi treatment in the rheumatology outpatient clinic. The patients were evaluated retrospectively, cross-sectionally and grouped by intensity of smoking (pack-years). Those who smoked>20 pack-years were defined as heavy smokers. Groups were compared in terms of physical examination, laboratory values and disease evaluation indexes (Bath Ankylosing Spondylitis Metrology Index (BASMI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Ankylosing Spondylitis Quality of Life (ASQoL) and Beck Depression Inventory (BDI) scores. Mann-Whitney U and Spearman correlation analysis tests were used for data analysis Results: Comparison of the smoker (n=121) and non-smoker groups (n=90) revealed BASMI was lower in the non-smoker group (p=0.04). Smoking intensity correlated with BDI (r=0.323, p<0.001), BASDAI (r=0.257, p=0.005), BASMI components (lomber lateral flexion (LLF) (r=-0.303, p=0.001), cervical rotation (CR) (r=-0.232, p=0.012), and tragus wall distance (TWD) (r=0.27, p=0.003)). Multivariate analysis revealed an association between the pack-years of smoking and the BASMI [regression coefficient (B)=0.067, standard error (SE)=0.22, 95%CI=0.02, 0.10; p=0.003],baseline (B=pretreatment)-last value (L.=posttreatment) difference of BASFI [B=-0.063, SE=0.02, 95%CI=-0.10, -0.20; p=0.003], of BASDAI [B=-0.047, SE=0.02, 95%CI=-0.08, -0.007; p=0.026], ASQoL [B=-0.125, SE=0.04, 95%CI=0.04, -0.20; p=0.003]. In heavy smokers, significant worsening was found in LLFL (p=0.01), CRL (p=0.04), TWDL (p=0.001), BASFIL (p=0.035) and BASMIL (p=0.001). Significant differences were found in the baseline (B) and last (L) BASDAI (p=0.042), BASFIL (p=0.002), BASFIB-L (p=0.07) and BASMI (p=0.03) values in the nonradiograpic-axSpA group in heavy smokers, compared to the AS group. Conclusion: Our study showed that smoking, especially heavy smoking, has a negative effect in every phase of axSpA. Smoking intensity may correlate with reduced response to TNFi.https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/FA05CA59BD824C8997FB734B51D2D46Aaxial spondyloarthritisankylosing spondylitisnon-radiographic axial spondyloarthiristumor necrosis factor inhibitor therapysmoking |
| spellingShingle | Özlem Pehlivan Yasemin Yalçınkaya Bahar Artım Esen Nihat Hüseyinsinoğlu Ahmet Gül Murat İnanç Mahdume Lale Öçal EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPY İstanbul Tıp Fakültesi Dergisi axial spondyloarthritis ankylosing spondylitis non-radiographic axial spondyloarthiris tumor necrosis factor inhibitor therapy smoking |
| title | EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPY |
| title_full | EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPY |
| title_fullStr | EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPY |
| title_full_unstemmed | EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPY |
| title_short | EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPY |
| title_sort | effects of smoking in patients with axial spondyloarthritis receiving tumor necrosis factor inhibitors therapy |
| topic | axial spondyloarthritis ankylosing spondylitis non-radiographic axial spondyloarthiris tumor necrosis factor inhibitor therapy smoking |
| url | https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/FA05CA59BD824C8997FB734B51D2D46A |
| work_keys_str_mv | AT ozlempehlivan effectsofsmokinginpatientswithaxialspondyloarthritisreceivingtumornecrosisfactorinhibitorstherapy AT yaseminyalcınkaya effectsofsmokinginpatientswithaxialspondyloarthritisreceivingtumornecrosisfactorinhibitorstherapy AT baharartımesen effectsofsmokinginpatientswithaxialspondyloarthritisreceivingtumornecrosisfactorinhibitorstherapy AT nihathuseyinsinoglu effectsofsmokinginpatientswithaxialspondyloarthritisreceivingtumornecrosisfactorinhibitorstherapy AT ahmetgul effectsofsmokinginpatientswithaxialspondyloarthritisreceivingtumornecrosisfactorinhibitorstherapy AT muratinanc effectsofsmokinginpatientswithaxialspondyloarthritisreceivingtumornecrosisfactorinhibitorstherapy AT mahdumelaleocal effectsofsmokinginpatientswithaxialspondyloarthritisreceivingtumornecrosisfactorinhibitorstherapy |